Neogen Chemicals IPO subscribed 27% on Day 1

The company had on Tuesday raised Rs 39.70 crore from seven anchor investors at Rs 215 per share.

Getty Images
At this price, the issue is commanding a P/E valuation of 47.8 times on a FY18 EPS of Rs 4.5, which is at a premium to its peer average of 38.8 times.
NEW DELHI: The initial public offering (IPO) by Neogen Chemicals got 27 per cent subscription on Day 1 of the bidding process on Wednesday.

Till 5 pm, the Rs 132-crore IPO received bids for 11,67,595 shares against the issue size of 43,29,038 units.

The company had on Tuesday raised Rs 39.70 crore from seven anchor investors at Rs 215 per share.


At this price, the issue is commanding a P/E valuation of 40.95 times on a FY18 EPS of Rs 5.25, which is at a premium to its peer average of 38.8 times. Given its presence in lithium-based chemicals used in batteries for electric vehicles, the company’s revenue potential is high.

But analysts say valuations are mostly pricing in earning prospects, leaving little room for short-term gains. One may subscribe to this IPO with a long-term horizon or give it a miss, multiple analysts said.

Neogen makes organic chemical compounds – Bromine compounds and other organic compounds containing chlorine, fluorine and iodine-based and combination – used in application industries such as pharmaceutical, agrochemical, flavour and fragrance and electronic chemicals.
ADVERTISEMENT

Besides, it makes inorganic chemicals primarily comprising lithium compounds used in vapour absorption machines (VAM) and heating ventilation and air-conditioning (HVAC) and refrigeration, construction chemicals, pharmaceutical and specialty polymer. Organic chemicals account for 60-70 per cent of the company’s revenues while the rest comes in from inorganic chemicals.

The company said its standalone total income and profit grew at a compounded annual growth rate (CAGR) of 19.66 per cent and 30.61 per cent, respectively, during FY14-18. On a consolidated basis, total income and profit after tax rose 19.69 per cent and 30.29 per cent, respectively.

Neogen Chemicals IPO set to open: Should you invest?
1/9
The Rs 132 crore initial public offering (IPO) of specialty chemicals firm Neogen Chemicals will hit the market on Wednesday. On the block are fresh issue of shares aggregating up to Rs 70 crore. The issue will close on April 26. Here are the key things about the company one should know before subscribing to the issue
The Rs 132 crore initial public offering (IPO) of specialty chemicals firm Neogen Chemicals will hit the market on Wednesday. On the block are fresh issue of shares aggregating up to Rs 70 crore. Th..
Read More
Neogen makes organic chemical compounds – Bromine compounds and other organic compounds containing chlorine, fluorine and iodine-based and combination – used in application industries such as pharmaceutical, agrochemical, flavour and fragrance and electronic chemicals. Besides, it makes inorganic chemicals primarily comprising Lithium compounds. These compounds are used in vapour absorption machines (VAM) and in heating ventilation and air-conditioning (HVAC) and refrigeration, construction chemicals, pharmaceutical and specialty polymer. Organic chemicals account for 60-70 per cent of the company’s revenues while the rest comes in from inorganic chemicals.
Neogen makes organic chemical compounds – Bromine compounds and other organic compounds containing chlorine, fluorine and iodine-based and combination – used in application industries such as pharmac..
Read More
The IPO consists of a fresh issue aggregating up to Rs 70 crore by the company and an offer for sale of up to 16,99,600 equity shares by Haridas Thakarshi Kanani and up to 12,00,400 shares by Beena Haridas Kanani (promoters). The issue price band is fixed at Rs 212-215 per share. Bids can be made for a minimum lot of 65 equity shares and in multiples of 65 equity shares thereafter. The anchor investor offer period will be one working day prior to the issue opening date, that is April 23. The company has aimed to raise Rs 131.48 crore at the lower end of price band and Rs 132.35 crore at the upper end.
The IPO consists of a fresh issue aggregating up to Rs 70 crore by the company and an offer for sale of up to 16,99,600 equity shares by Haridas Thakarshi Kanani and up to 12,00,400 shares by Beena H..
Read More
* Expanding production capacities
* Increasing contract manufacturing portfolio
* Augmenting growth in domestic and global markets
* Improving financial performance through focus on operational efficiencies and functional excellence
* Focus on advanced specialty intermediates which offer higher value addition
* Expanding production capacities * Increasing contract manufacturing portfolio * Augmenting growth in domestic and global markets * Improving financial performance through focus on operational e..
Read More
The company said its standalone total income and profit grew at a compounded annual growth rate (CAGR) of 19.66 per cent and 30.61 per cent, respectively, in FY14-18. On a consolidated basis, total income and profit after tax rose 19.69 per cent and 30.29 per cent, respectively, during this period.
The company said its standalone total income and profit grew at a compounded annual growth rate (CAGR) of 19.66 per cent and 30.61 per cent, respectively, in FY14-18. On a consolidated basis, total i..
Read More
* Experienced promoters with domain knowledge
* Large and diverse array of products
* Diversified and stable customer base
* Growth led by continuous investment in R&D
* Management expertise
* Specialised business model with high entry barriers
* Established and stable relationship with suppliers

By: HDFC securities Limited
* Experienced promoters with domain knowledge * Large and diverse array of products * Diversified and stable customer base * Growth led by continuous investment in R&D * Management expertise * ..
Read More
* Neogen Corporation has filed a commercial intellectual property suit against NCL which if determined against NCL may have an adverse effect on this Offer, its business and results of operations.
* Absence of any firm commitment long-term agreements with customers
* Significant reliance on certain select customers and customers in application industries, in particular customers in the sectors such as- pharmaceutical, agro-chemicals, refrigeration and construction chemicals
* Failure to identify and understand evolving industry trends and preferences and to develop new products to meet customers' demands
* Changes in the value of the Indian rupee and other currencies
* Inability to accurately forecast demand for products, and accordingly manage inventory or plan capacity increases
* Indebtedness and the conditions and restrictions imposed on NCL by its financing agreements
* Increased costs on account of compliance with various law and regulations
* Neogen Corporation has filed a commercial intellectual property suit against NCL which if determined against NCL may have an adverse effect on this Offer, its business and results of operations. *..
Read More
The maker of organic and inorganic chemicals has many listed peers, including Aarti Industries, Atul, Navin Fluorine International, Vinati Organics and Paushak. These stocks have had a good run in last three years. At the upper end of the issue price of Rs 215, the IPO is demanding a PE of 40.56 (At FY18 EPS of Rs 5.3). Aarti Industries and Atul Industries trade at FY18 multiples of 39-40, while Vinati Organics, Paushak and Navin Flourine trade at 20-58 times.
The maker of organic and inorganic chemicals has many listed peers, including Aarti Industries, Atul, Navin Fluorine International, Vinati Organics and Paushak. These stocks have had a good run in la..
Read More
By 2022, the global specialty chemicals market is expected to grow at 5.47 per cent CAGR to $970.55 billion. The steady growth is because of sustained demand in end-user industries. In India, the industry is highly fragmented, with small and medium enterprises comprising 70-75 per cent market share. Analysts say growth opportunities are immense in this space.
By 2022, the global specialty chemicals market is expected to grow at 5.47 per cent CAGR to $970.55 billion. The steady growth is because of sustained demand in end-user industries. In India, the ind..
Read More

ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › IPOs/FPOs › Neogen Chemicals IPO subscribed 27% on Day 1
Text Size:AAA
Success
This article has been saved

*

+